摘要 |
<p>A method and medicament for treating mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproloferative disorder, or non-MLL based acoute lymphoid leukemia is provided, wherein the active agent used is the GSK-3 inhibitor 7- (2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-lH-pyrrol-3-yl) -9-fluoro-1,2,3, 4-tetrahydro-2- (1-piper idinylcarbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine or a pharmaceutically acceptable salt or salvate thereof.</p> |